Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Screening for cystic fibrosis in New York State: considerations for algorithm improvements.

European journal of pediatrics - 1 Feb 2016

Kay Denise M, Maloney Breanne, Hamel Rhonda, Pearce Melissa, DeMartino Lenore, McMahon Rebecca, McGrath Emily, Krein Lea, Vogel Beth, Saavedra-Matiz Carlos A, Caggana Michele, Tavakoli Norma P

Abstract excerpt

Newborn screening for cystic fibrosis (CF), a chronic progressive disease affecting mucus viscosity, has been beneficial in both improving life expectancy and the quality of life for individuals with CF. In New York State from 2007 to 2012 screening for CF involved measuring immunoreactive trypsinogen (IRT) levels in dried blood spots from newborns using the IMMUCHEM(™) Blood Spot Trypsin-MW ELISA kit. Any...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Algorithms
Share to Cystic Fibrosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cystic Fibrosis Transmembrane Conductance Regulator

Share to Neonatal Screening

Share to New York

Share to Prevalence

Share to Sensitivity and Specificity

Share to Trypsinogen

Source

Identifiers

PMID: 26293390
DOI: 10.1007/s00431-015-2616-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Screening for cystic fibrosis in New York State: considerations for algorithm improvements.PMID 26293390Read ↗

Improving the Sensitivity and Positive Predictive Value in a Cystic Fibrosis Newborn Screening Program Using a Repeat Immunoreactive Trypsinogen and Genetic Analysis.Semantic proximity Read ↗

Newborn Screening for Cystic Fibrosis in California.Semantic proximity Read ↗

Improving outcomes for Colorado's IRT-IRT-DNA cystic fibrosis newborn screening algorithm by implementing floating cutoffs.Semantic proximity Read ↗

Utility of a very high IRT/No mutation referral category in cystic fibrosis newborn screening.Semantic proximity Read ↗

Variation in cystic fibrosis newborn screening algorithms in the United States.Semantic proximity Read ↗

A new cystic fibrosis newborn screening algorithm: IRT/IRT1 upward arrow/DNA.Semantic proximity Read ↗

Cystic fibrosis newborn screening: using experience to optimize the screening algorithm.Semantic proximity Read ↗

Immunoreactive Trypsinogen in Infants Born to Women with Cystic Fibrosis Taking Elexacaftor–Tezacaftor–IvacaftorSemantic proximity Read ↗

New York Cystic Fibrosis Newborn Screening Consortium Quality Improvement: Focus on Parent and Pediatrician Education and Develop a Statewide Standard of Care for CF-Related Metabolic Syndrome infants.Semantic proximity Read ↗

Current Status of Genetic Diagnosis Laboratories and Frequency of Genetic Variants Associated with Cystic Fibrosis through a Newborn-Screening Program in Turkey.Semantic proximity Read ↗

Clinical Sensitivity of Cystic Fibrosis Mutation Panels in a Diverse Population.Semantic proximity Read ↗

Cystic fibrosis newborn screening in a high prevalence population - Ten years' experience in Ireland.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.